Advanced search
Publication Cover
Clinical Toxicology Volume 45, 2007 - Issue 3
Submit an article Journal homepage
196
Views
13
CrossRef citations to date
0
Altmetric
Case Report

Zuclopenthixol-induced neuroleptic malignant syndrome in an adolescent girl

Serpil Erermis Associate Professor, Ege University, School of Medicine, Department of Child Psychiatry, Izmir, Turkey
, M.D.,
Tezan Bildik Assistant Professor, Ege University, School of Medicine, Department of Child Psychiatry, Izmir, Turkey
, M.D.,
Muge Tamar Associate Professor, Ege University, School of Medicine, Department of Child Psychiatry, Izmir, Turkey
, M.D.,
Ahmet Gockay Associate Professor, Ege University, School of Medicine, Department of Neurology, Pediatric Neurology Unit, Izmir, Turkey
, M.D.,
Hatice Karasoy Professor, Ege University, School of Medicine, Department of Neurology, Pediatric Neurology Unit, Izmir, Turkey
, M.D. &
Eyup Sabri Ercan Associate Professor, Ege University, School of Medicine, Department of Child Psychiatry, Izmir, Turkey
, M.D.
Pages 277-280 | Received 23 May 2005, Accepted 09 Nov 2005, Published online: 07 Oct 2008

References

  • Kemperman CJ. Zuclopenthixol-induced neuroleptic malignant syndrome at rechallenge and its extrapyramidal effects. Br J Psychiatry 1989; 154: 562–563
  • Hynes AFM, Vickar EL. Case Study: Neuroleptic malignant syndrome without pyrexia. J Am Acad Child Adolsc Psych 1996; 35: 959–962
  • Ty EB, Rothner AD. Neuroleptic malignant syndrome in children and adolescents. J Child Neurol 2001; 16: 157–163
  • Silva RR, Munoz DM, Alpert M, Perlmuter IR, Diaz J. Neuroleptic malignant syndrome in children. J Am Acad Child Adolsc Psych 1999; 38: 187–194
  • American Psychiatric Association (APA). Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Association, Washington, DC 2000; 795–798
  • Pope HG, Keck PE, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry 1986; 143: 1227–1233
  • Lev R, Clark RF. Neuroleptic malignant syndrome presenting without fever: Case report and review of the literature. J Emerg Med 1994; 12: 49–55
  • Sullivan CF. A possible variant of the neuroleptic malignant syndrome. Br J Psychiatry 1987; 151: 689–690
  • Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry 1985; 142: 1137–1145
  • Pelonero AL, Levenson JL, Pandurangi AK. Neuroleptic malignant syndrome: a review. Psychiatric Services 1998; 49: 1163–1172
  • Nierenberg D, Disch M, Manheimer E, Patterson J, Ross J, Silvestri G, Summerhill E. Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome. Clinical Pharmacology and Therapeutics 1991; 50: 580–586
  • Seitz Dallas P. Diagnostic uncertainty in a case of neuroleptic malignant syndrome. Can J Emerg Med 2005; 7: 266–273
  • Velamoor VR, Norman RM, Caroff SN. Progression of symptoms in neuroleptic malignant syndrome. J Nerv Ment Dis 1994; 182: 168–173
  • Sachdev P, Mason C, Hadzi-Pavlovic H. A case controlled study of neuroleptic malignant syndrome. American Journal of Psychiatry 1997; 154: 1156–1158
  • Bristow MF, Kohen D. Clinical awareness of neuroleptic malignant syndrome. Royal Soc Med 1996; 7: 31–35
  • Velamoor VR, Fernando MLD, Williamson P. Incipient neuroleptic malignant syndrome. British Journal of Psychiatry 1990; 156: 581–584
  • Berardi D, Amore M, Keck PE, Jr, Troia M, Dell'Atti M. Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case–control study. Biological Psychiatry 1998; 44: 748–754
  • Viejo LF, Morales V, Punal P, Perez JL, Sancho RA. Risk factors in neuroleptic malignant syndrome. A case–control study. Acta Psychiatr Scand 2003; 107: 45–49
  • Joshi PT, Capozzoli JA, Coyle JT. Neuroleptic malignant syndrome: Life-threatening complication of neuroleptic treatment in adolescents with affective disorder. Pediatrics 1991; 87: 235–239
  • Adityanjee Mathews T, Aderibigbe YA. Proposed research diagnostic criteria for neuroleptic malignant syndrome. Int J Neuropsychopharmacol 1999; 2: 129–144
  • Caroff SN, Mann SC. Neuroleptic malignant syndrome. Medical Clinics of North America 1993; 77: 185–202

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.